- socially bharat
- October 25, 2024
Aker ASA: Presentation of Third-Quarter Results 2024
Aker ASA will publish its financial results for the third quarter of 2024 on Wednesday, November 6, 2024, at 07:00 CET.
READ MORE
- socially bharat
- October 6, 2024
Environmental Factor – April 2019: Fellows hone presentation skills in communication showdown
Fourteen pre- and postdoctoral trainees participated in this year’s Big Picture, Small Talk Communication Challenge, during which they presented a plain-language speech about their research.
- socially bharat
- October 4, 2024
Invitation to presentation of HEXPOL’s Interim Report Q3 on 25 October
HEXPOL will release the Interim Report for the third quarter 2024 on Friday 25 October at about 13:00 CET. The
- socially bharat
- October 3, 2024
Invitation to the presentation of Gjensidige’s results for the 3rd quarter 2024
Gjensidige Forsikring (OSE:GJF) will publish the results for the 3rd quarter 2024 on 22 October at 7.00 CET. 22 October
- socially bharat
- October 2, 2024
Invitation to Hoist Finance third quarter 2024 presentation
PRESS RELEASE Stockholm 02 October 2024 Hoist Finance will publish its Q3 2024 report on 25 October 2024, at
- socially bharat
- September 27, 2024
Invitation to conference call and webcast presentation of Dometic’s Q3 2024 interim report
Dometic Group AB (publ) will publish its Q3 2024 interim report at around 07.30 CEST on Wednesday, October 23, 2024.
- socially bharat
- September 25, 2024
Atrium Ljungberg is hosting a presentation of Q3 Report 2024 on 11 October at 10.15 CET
Atrium Ljungberg is hosting an online broadcast of the Q3 Report 2024 presentation at 10.15 CET on 11 October. The Q3
- socially bharat
- September 24, 2024
Circio selected for oral presentation at ESGCT 2024 annual meeting
Circio has been selected to present its circVec circular RNA expression platform at the European Society of Cell and Gene Therapy
- socially bharat
- September 20, 2024
Neuraptive Therapeutics Announces Presentation of Phase 2 Topline Interim Results for NTX-001 at the 2024 American Society for Surgery of the Hand (ASSH) Annual Meeting
Chesterbrook, Pa., United States: Neuraptive Therapeutics Inc., a leading biopharmaceutical company focused on novel treatments for peripheral nerve injuries, today
- socially bharat
- September 20, 2024
UNION therapeutics to present orismilast Phase 2b results in atopic dermatitis as a late-breaking oral presentation at the EADV Congress 2024
ADESOS Phase 2b results with orismilast in atopic dermatitis (AD) selected as late-breaking oral presentation Additionally, two posters on data